Merkel cell carcinoma: a case report

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Merkel cell carcinoma is a rare and aggressive cutaneous neuroendocrine malignancy that presents as a persistent red-purplish, asymptomatic and rapidly growing nodule. It typically affects sun-exposed skin of white elderly individuals. In addition, risk factors for Merkel cell carcinoma include immunosuppression, as well as the presence of multiple myeloma or a history of chronic lymphocytic leukemia.

To diagnose Merkel cell carcinoma, five criteria of the AEIOU algorithm proposed in 2008 by a group of scientists at the University of Washington are used.

From the methods of laboratory diagnostics a detailed analysis of blood is used, also a histological and immunohistochemical study is carried out . Among the methods of instrumental diagnostics, ultrasound examination of the primary tumor and groups of lymph nodes of the appropriate localization, abdominal and pelvic organs; chest X-ray and skeletal bone scintigraphy; positron emission tomography combined with X-ray computed tomography are mandatory. A sentinel node biopsy followed by histological and immunohistochemical examination is recommended in the absence of metastatic lymph node lesions.

We herein contribute by reporting a case of Merkel cell carcinoma affecting the forearm of a 51-year-old female. This clinical case confirms the aggressiveness of this type of the skin cancer as well as high possibility of misdiagnosis due to the scarce occurrence of Merkel cell carcinoma and lack of professional knowledge.

Therefore, it is important for the practitioners involved in the care of skin lesions to be aware of this condition and the need for a multidisciplinary treatment approach.

Full Text

Restricted Access

About the authors

Ekaterina Yu. Vertieva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: ivertieva@gmail.com
ORCID iD: 0000-0002-1088-2911
SPIN-code: 3712-8453

MD, Cand. Sci. (Med.)

Russian Federation, 8, buil. 2, Trubetskaya street, Moscow, 119991

Alexander S. Tertychnyy

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: atertychyy@gmail.com
ORCID iD: 0000-0001-5635-6100
SPIN-code: 5150-0535

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Anna D. Dubinich

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: aniu.dubini4@yandex.ru

MD

Russian Federation, Moscow

Zoya E. Konstantinova

Chaika Health

Email: zoe4ka@bk.ru

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

References

  1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107–110.
  2. Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1. NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(6):742–774. doi: 10.6004/jnccn.2018.0055
  3. Clinical recommendations of “Merkel’s Carcinoma”. Ed. by Ya.V. Vishnevskaya, et al. Moscow: GEOTAR-Media; 2017. 29 p. (In Russ).
  4. Kervarrec T, Samimi M, Guyétant S, et al. Histogenesis of merkel cell carcinoma: a comprehensive review. Front Oncol. 2019;9:451. doi: 10.3389/fonc.2019.00451
  5. DeCaprio JA. Molecular pathogenesis of merkel cell carcinoma. Annu Rev Pathol. 2021;16:69–91. doi: 10.1146/annurev-pathmechdis-012419-032817
  6. Schadendorf D, Lebbé C, Hausen A, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017;71:53–69. doi: 10.1016/j.ejca.2016.10.022
  7. Becker JC, Kauczok CS, Ugurel S, et al. Merkel cell carcinoma: Molecular pathogenesis, clinical features and therapy. JDDG J Ger Soc Dermatology. 2008;6:709–719. doi: 10.1111/j.1610-0387.2008.06830.x
  8. Dellambra E, Carbone ML, Ricci F, et al. Merkel Cell Carcinoma. Biomedicines. 2021;9(7):718. doi: 10.3390/biomedicines9070718
  9. Harms KL, Healy MA, Nghiem P, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol. 2016;23(11):3564. doi: 10.1245/s10434-016-5266-4
  10. Schadendorf D, Lebbé C, Hausen A, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017;71:53–69. doi: 10.1016/j.ejca.2016.10.022
  11. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375. doi: 10.1016/j.jaad.2007.11.020

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Patient K., 51 years old, diagnosis of Merkel cell carcinoma: view of the neoplasm from above (a) and from the side (b).

Download (450KB)
3. Fig. 2. Immunohistochemical examination: a ― tumor growth in the dermis (staining with hematoxylin and eosin, × 200); b ― characteristic positive point perinuclear staining of tumor cells in reaction with SC20 (immunohistochemical reaction, × 200); c ― diffuse positive cytoplasmic staining of tumor cells in reaction with synaptophysin (immunohistochemical reaction, × 200).

Download (909KB)

Copyright (c) 2022 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies